Remove Clinic Remove Manufacturing Remove Medical Remove Screening
article thumbnail

AAFP Represents Members During 2025 Legislative Session

Alabama Academy of Family Physicians

Bill Easing Volunteer Rules for Retired Physicians Awaits Governor’s Signature What’s in the Bill: HB 346 streamlines volunteer opportunities for retired physicians at free health clinics is headed to the Governor for final approval. HB 45 – Medicaid Coverage for Cologuard Test What’s in the Bill: Sponsored by Rep.

Insurance 130
article thumbnail

Lots of FDA Guidance, But Few Drug Manufacturing “Remote Interactive Evaluations” (We Would Call Them “Virtual Inspections”)

FDA Law

A phone call to FDA requested information about the number of Remote Interactive Evaluations (RIEs) that FDA has performed at drug manufacturing facilities since it announced in April 2021 that it would start using them as an alternative to on-site inspections.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Future Of Vision And Eye Care

The Medical Futurist

The 80-year-old Ray Flynn lost his central vision entirely, but with the help of the retinal implant, he could make out shapes on the computer screen. However, things are moving fast, and success doesn’t come easy for the pioneers of any medical field. The drug helped decrease the initial healing from 5 days.

Diabetes 105
article thumbnail

New Draft Guidance Provides Detailed (and Burdensome) Recommendations for Chemical Assessments to Support Medical Device Biocompatibility

FDA Law

Chemical characterization identifies and quantifies chemicals that may be released from the medical device, while a toxicological risk analysis (TRA) evaluates the risks to the patient associated with the chemicals identified. Chemical characterization can also be useful in evaluating a change to the materials or manufacturing of a device.

article thumbnail

We Have an LDT Proposed Rule!

FDA Law

For more than 30 years, FDA has asserted that it has jurisdiction to regulate LDTs as medical devices and clinical laboratories as manufacturers. These LDTs are performed in clinical laboratories regulated under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

article thumbnail

COVID At-Home Antigen Tests: If at First You Don’t Succeed Try, Try and Try Again

FDA Law

Baumhardt, Senior Medical Device Regulation Expert & Richard A. The 80% sensitivity requirement for antigen tests has yet to be explained either scientifically or clinically by the Agency. The primary barrier to bringing new antigen tests to market has been FDA’s minimum requirement of 80% sensitivity for authorization.

article thumbnail

Urinary Incontinence Revisited: George Kuchel & Alison Huang

GeriPal

Accreditation In support of improving patient care, UCSF Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IT 120